Friday, January 05, 2007

Acorda Therapeutics to Present at the 25 th Annual JP Morgan ...
Business Wire (press release) - San Francisco,CA,USA
Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of ...

Improved Quarter for Biotech on Capital Markets ... and Financings ...
CNW Telbec (Communiqués de presse) - Canada
Its shares took off in September after it had announced that its Phase III trial on Fampridine-SR its multiple sclerosis treatment, improved patients' ...


Take Action
Take Action

New Congress to Address Stem Cell Legislation

Support the Stem Cell Research Enhancement Act

Take Action!


The new 110th Congress brings another significant opportunity to pass federal stem cell legislation and help us move closer to a world free of multiple sclerosis. The Stem Cell Research Enhancement Act (H.R. 3 and S. 5) has been introduced and is expected to move quickly through both chambers. In fact, the House has announced its intention to vote on H.R. 3 on January 11.

Now is the time to introduce ourselves to the new Congress and let the members know that MS activists support the Stem Cell Research Enhancement Act. The more we call and e-mail, the more we can ensure the voices of MS activists are heard.

Call Congress
As a constituent, your personal phone call to a member of Congress can make a meaningful impression. Take a moment today to call. Go through the Capitol switchboard at 1-800-828-0498 and ask for your Representative and Senators. When you reach their office, identify yourself and where you are from. Then use these talking points:

  • I’m calling to ask for your support of the Stem Cell Research Enhancement Act. Vote yes.
  • Now is the time to expand the embryonic stem cell lines available for federally funded research and move us closer to a world free of multiple sclerosis.
  • I’m an MS activist, and I urge you to co-sponsor this bill and vote yes to enact this important legislation. The promise of MS research depends on it.

These first few days of Congress will be busy and it is critical that we make a great first impression as an organization. Remember to be polite but firm. You might try several times before your call is answered, and don't be surprised if your Representative or Senator answers the phone.

Send an E-Mail
If you would prefer to send a brief e-mail, click above to take action. A thoughtful note can add emphasis to other constituent phone calls. In the event that e-mail information for a new member of Congress is not yet available, we encourage you to call instead.

Our Position
The Society believes that all promising avenues that could lead to the cure or prevention of MS or relieve its most devastating symptoms by repairing MS damage must be explored — including expanding the number of approved embryonic stem cell lines that are available for federally funded research. To help remedy the current federal policy, the Society supports this newly introduced legislation. The Stem Cell Research Enhancement Act allows new stem cell lines to be generated from embryos that have been donated for research purposes by people using the services of in vitro fertilization clinics, while establishing important ethical protections. Click here for more information on our position.

We are encouraged that the new Congress has identified federal funding of embryonic stem cell research as a legislative priority, and we feel confident in its broad support with legislators and the public. Be sure to take action today, and thank you for being an MS activist.

NMSS Logo


If you no longer wish to receive e-mail from us, please click here.





Uric Acid And Spinal Cord Injury Treatment - A Novel Approach From Rutgers Holds Potential For Central Nervous System ...
Medical News Today Fri, 05 Jan 2007 0:02 AM PST
Uric acid is commonly associated with the excruciatingly painful joint disease known as gout, but it can also play a crucial role in the treatment of spinal cord injury and other central nervous system disorders, such as stroke, multiple sclerosis and Parkinson’s disease, according to Rutgers’ Bonnie Firestein. [click link for full article]

For Kids, MS Itself Just Half the Battle
RedNova Fri, 05 Jan 2007 6:16 AM PST
CHICAGO _ Tiffany Jones stood before her classmates at Hillcrest High School, trembling with emotion. It was time to present her anatomy class project _ and reveal a secret she'd closely guarded.

Research and Markets: Pfizer and Glaxosmithkline Are Two Major Drug Developers Actively Seeking to Reposition Their ...
Business Wire via Yahoo! Finance Fri, 05 Jan 2007 8:00 AM PST
DUBLIN, Ireland----Research and Markets has announced the addition of Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease to their offering.

For stem cell therapy, patients call Tampa
St. Petersburg Times Thu, 04 Jan 2007 10:18 PM PST
After New York City chiropractor Rich James had a stroke in February, he kept reading accounts of people with stroke-related paralysis being treated with stem cells at clinics outside the United States.

Taking things slow can be best
Baltimore Sun Fri, 05 Jan 2007 5:33 AM PST
Exercise has slowly - very slowly - changed Jan Love's life.

Health calendar
Pioneer Press Fri, 05 Jan 2007 1:23 AM PST
Ongoing in January Wellness classes. Tai chi, power yoga, meditation, Iyengar yoga, hypnosis for weight loss, Pilates mat and gentle yoga. Healing Waters Ltd. in White Bear Lake. Various times and fees. 651-653-1660.

For stem cell therapy, patients call Tampa
St. Petersburg Times Thu, 04 Jan 2007 6:14 PM PST
Treatments aren’t allowed in the United States, so the company connects with clinics overseas.

The Immune Response Corporation Announces Receipt of Milestone Payment From NovaRx Corporation
RedNova Thu, 04 Jan 2007 9:11 PM PST
CARLSBAD, Calif., Jan. 4 /PRNewswire-FirstCall

Doctors weigh potential U.S. stem cell research funding changes
CBC Thu, 04 Jan 2007 2:59 PM PST
A U.S. law easing restrictions on stem cell research could be introduced as early as Friday, after Congress convened this week.


0 Comments:

Post a Comment

<< Home